跳至主要内容
临床试验/EUCTR2017-004497-33-DK
EUCTR2017-004497-33-DK进行中(未招募)1 期

Measuring effects on pain and quality of life after Dysport® injection in children with cerebral palsy

Copenhagen University Hospital at Hvidovre0 个研究点目标入组 36 人开始时间: 2017年12月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Diagnosed with spastic cerebral palsy
  • - GFMCS 1-5.
  • - Age 2-18
  • - Having a pain response by the revised and individualized Face Legs Activity Cry and Consolability (rFLACC) for muscles with spasticity (MAS score = 1 and a spasticity grade of 1-4 on the Tardieu scale) during the passive range of motion by the treating physician.
  • - Requiring BonTA injection for their spasticity
  • - having had a washout period of at least 6 month from last injection of botulinum toxin
  • - Dynamic Myocontracture /spasticity in the painful limb (MAS score = 1 and a spasticity grade of 1-4 on the Tardieu scale)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 36
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Fixed myocontracture (Reduced and static passive range of motion)
  • - Severe athetoid/dystonic movements in the targeted leg(s)
  • Relative exclusion criteria
  • Prior and recent surgery that might influence the pain evaluation is a contraindication and will be evaluated on an individual basis for the specific test subject by the principle investigator.

研究者

发起方
Copenhagen University Hospital at Hvidovre

相似试验